Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041062-24-000200
Filing Date
2024-11-14
Accepted
2024-11-14 12:51:31
Documents
1
Group Members
BRANDES INVESTMENT PARTNERS, L.P.BRANDES WORLDWIDE HOLDINGS, L.P.CO-GP, LLCGLENN CARLSON

Document Format Files

Seq Description Document Type Size
1 13G Phibro_Animal.txt SC 13G/A 11457
  Complete submission text file 0001041062-24-000200.txt   13623
Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

EIN.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-88114 | Film No.: 241459587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)